Micrima is pleased to announce after a professional search to find a new CEO with the right blend of MedTech and commercial experience, we have appointed Adrian Waller who will start on the 1st Jan 2021. Adrian has extensive Medical device experience together with a technical background (aerospace engineering) and for the last six years has been General Manager of Fujifilm Medical`s diagnostic medical-imaging business in the UK. During that time he was responsible for all UK activities, including commercial which grew significantly, in all areas, under his leadership. Prior to Fujifilm, Adrian spent three years with GE Healthcare where he was brought in to assist and restructure the team as they exited the National Programme for IT (NPfIT) before helping them commercialise a range of very specialised IT Solutions for the MedTech sector.
Adrian said in a brief statement to investors “I’m incredibly excited about joining Micrima at such a key stage of its development. The potential of the MARIA® system to transform the diagnosis of breast cancer is clear and the opportunity to work with the team to accelerate the products adoption and continued development was something that I had to get involved with. I’m really looking forward to joining the team in the new year and using my market knowledge, network, and business management skills to help Micrima make a difference to the ~600k ladies that die of breast cancer, every year” We look forward to a more in-depth article with Adrian when he formally joins the company in 2021